
Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Oculeve, today announced that they have entered into an agreement under which Allergan will acquire Oculeve.
Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Oculeve, today announced that they have entered into an agreement under which Allergan will acquire Oculeve.
The prominent award recognizes the efforts of AkzoNobel and development partners The FReMCo Group and The Gold Standard Foundation.
Cardinal Health today announced the completion of its acquisition of the Harvard Drug Group, a distributor of generic pharmaceuticals, over-the-counter medications.
Anita Gupta, D.O., , testified before the U.S. Food and Drug Administration in support of expanded access to Naloxone, a medication that can rapidly reverse an opioid overdose.
Police say they have caught the man responsible for burning down the Baltimore CVS during the Freddie Gray riots.
Moving away from the pay-per-pill standard, Novartis will attempt a new pricing model based on clinical outcomes for its widely anticipated chronic heart failure (HF) drug.
Anne Burns, RPh, vice president of professional affairs for the American Pharmacists Association, talks about financial incentives for pharmacists to improve quality of care.
Asthma's increasingly deleterious morbidity and socioeconomic burden are of tremendous concern to clinicians and public health officials.
Teva has launched a generic version of aspirin and extended-release dipyridamole (Aggrenox) capsules in the United States.
Many states implement unlawful and life-threatening restrictions on Medicaid coverage for the hepatitis C virus drug, sofosbuvir.
Anne Burns RPh Vice President of Professional Affairs at the American Pharmacists Association talks about the changes that pharmacists can expect to see in the coming years.
To win the health care relay race, one clinician needs to pass the baton to the next clinician, who must be ready to receive it.
A Publix pharmacy technician has been fired and arrested after confessing to stealing Vicodin to pay for her gas money and other car expenses.
Chemotherapy-induced neutropenia (CIN) is a common adverse occurrence in patients treated for solid tumors.
Anne Burns, RPh, talks about the effect on pharmacy that the Department of Health and Human Services decision to tie reimbursement to quality will have.
The FDA is taking enforcement actions against manufacturers and distributors of unapproved prescription eardrops.
A federal judge has entered a consent decree of permanent injunction against a manufacturing company for marketing unapproved and misbranded prescription drugs.
Marshall Health officially opened the doors to a new retail pharmacy in the Erma Ora Byrd Clinical Center on the Marshall University Joan C. Edwards School of Medicine's health sciences campus.
Anne Burns, RPh, vice president of professional affairs for the American Pharmacists Association, offers a few ideas as to how community pharmacists can improve collaboration.
There has been a lot of talk about rising specialty drug prices and how they will affect health care costs.
The American Pharmacists Association announced a call for candidates in the 2016 APhA Board of Trustees and the APhA-Academy of Pharmacy Practice and Management.
Sarah Scoular, PharmD, BCPS, assistant professor at the University of Colorado Skaggs School of Pharmacy, discusses some of the international work she has been involved in.
This weekly video program highlights the latest in pharmacy news, product news, and more.
Health care professionals should stop using dosing cups that measure in drams.
A CVS pharmacist's keen eye caught 2 men allegedly trying to pass off fake prescriptions, which led to their arrests.
Are you familiar with these pharmacy laws?
SpartanNash store pharmacies will be hosting free DermaView Screenings in July at select locations to help the community assess their risk for skin damage.
The FDA is investigating potential risks associated with codeine-containing medicines to treat coughs and colds in children aged under 18 years.
Boehringer Ingelheim today announced regulatory authority approvals for Spiolto® Respimat® (tiotropium/olodaterol) in first European countries.
Biogen and AGTC today announced a broad collaboration and license agreement to develop gene-based therapies for multiple ophthalmic diseases.